JP2002537022A

JP2002537022A - 軟骨病変を再生して修復する装置及び方法

軟骨病変を再生して修復する装置及び方法

Info

Publication number: JP2002537022A
Authority: JP; Japan
Prior art keywords: protein; mixture; bmp; cartilage; product
Prior art date: 1999-02-16
Legal status : Pending

Application number

JP2000599344A

Other languages

English (en)

Japanese (ja)

Other versions

JP2002537022A5 (enExample

Inventor

アトキンソン、ブレント

ジェイ．ベネディクト、ジェームス

Original Assignee

ズルツァーバイオロジクスインコーポレイテッド

Priority date

1999-02-16

Filing date

2000-02-16

Publication date

2002-11-05

1999-02-16 Priority claimed from US09/250,370 external-priority patent/US6514514B1/en

2000-02-16 Application filed by ズルツァーバイオロジクスインコーポレイテッド filed Critical ズルツァーバイオロジクスインコーポレイテッド

2002-11-05 Publication of JP2002537022A publication Critical patent/JP2002537022A/ja

2007-04-05 Publication of JP2002537022A5 publication Critical patent/JP2002537022A5/ja

Status Pending legal-status Critical Current

Links

210000000845 cartilage Anatomy 0.000 title claims abstract description 412
238000000034 method Methods 0.000 title claims abstract description 122
230000003902 lesion Effects 0.000 title claims abstract description 77
230000001172 regenerating effect Effects 0.000 title abstract description 8
230000008439 repair process Effects 0.000 claims abstract description 238
230000007547 defect Effects 0.000 claims abstract description 77
230000002792 vascular Effects 0.000 claims abstract description 28
210000001188 articular cartilage Anatomy 0.000 claims abstract description 8
230000024245 cell differentiation Effects 0.000 claims abstract description 8
239000000203 mixture Substances 0.000 claims description 664
108090000623 proteins and genes Proteins 0.000 claims description 626
102000004169 proteins and genes Human genes 0.000 claims description 621
239000011159 matrix material Substances 0.000 claims description 174
102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 140
108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 139
210000000988 bone and bone Anatomy 0.000 claims description 125
102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 114
108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 114
230000002648 chondrogenic effect Effects 0.000 claims description 93
230000001939 inductive effect Effects 0.000 claims description 90
229940112869 bone morphogenetic protein Drugs 0.000 claims description 77
102000008186 Collagen Human genes 0.000 claims description 55
108010035532 Collagen Proteins 0.000 claims description 55
229920001436 collagen Polymers 0.000 claims description 55
239000003102 growth factor Substances 0.000 claims description 53
108010049951 Bone Morphogenetic Protein 3 Proteins 0.000 claims description 51
102100024504 Bone morphogenetic protein 3 Human genes 0.000 claims description 51
108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 claims description 49
102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims description 49
230000002188 osteogenic effect Effects 0.000 claims description 49
210000002805 bone matrix Anatomy 0.000 claims description 44
238000003556 assay Methods 0.000 claims description 42
238000009472 formulation Methods 0.000 claims description 42
108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims description 41
102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims description 41
108060003393 Granulin Proteins 0.000 claims description 40
238000007920 subcutaneous administration Methods 0.000 claims description 35
102000016921 Integrin-Binding Sialoprotein Human genes 0.000 claims description 30
108010028750 Integrin-Binding Sialoprotein Proteins 0.000 claims description 30
108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 claims description 27
102100022525 Bone morphogenetic protein 6 Human genes 0.000 claims description 27
238000002360 preparation method Methods 0.000 claims description 27
102000004506 Blood Proteins Human genes 0.000 claims description 25
108010017384 Blood Proteins Proteins 0.000 claims description 25
102000007453 TGF-beta Superfamily Proteins Human genes 0.000 claims description 24
108010085004 TGF-beta Superfamily Proteins Proteins 0.000 claims description 24
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 24
108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 claims description 23
102100022526 Bone morphogenetic protein 5 Human genes 0.000 claims description 23
241000283690 Bos taurus Species 0.000 claims description 23
102000004067 Osteocalcin Human genes 0.000 claims description 22
108090000573 Osteocalcin Proteins 0.000 claims description 22
108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 claims description 21
102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims description 21
102000009890 Osteonectin Human genes 0.000 claims description 21
108010077077 Osteonectin Proteins 0.000 claims description 21
230000036961 partial effect Effects 0.000 claims description 21
108010003894 Protein-Lysine 6-Oxidase Proteins 0.000 claims description 20
102100026858 Protein-lysine 6-oxidase Human genes 0.000 claims description 20
108010028075 procathepsin L Proteins 0.000 claims description 20
108010088751 Albumins Proteins 0.000 claims description 18
102000009027 Albumins Human genes 0.000 claims description 18
102000004338 Transferrin Human genes 0.000 claims description 18
108090000901 Transferrin Proteins 0.000 claims description 18
210000001612 chondrocyte Anatomy 0.000 claims description 18
239000012581 transferrin Substances 0.000 claims description 18
OKAHFCCFNVPTED-UHFFFAOYSA-N 3-(2-aminoethyl)-4-methyl-1h-indole-5,6-diol;2-amino-3-methyl-4h-imidazol-5-one;sulfuric acid Chemical compound OS(O)(=O)=O.CN1CC(=O)N=C1N.CC1=C(O)C(O)=CC2=C1C(CCN)=CN2 OKAHFCCFNVPTED-UHFFFAOYSA-N 0.000 claims description 16
108010033978 factor XIIIb Proteins 0.000 claims description 16
210000002435 tendon Anatomy 0.000 claims description 16
102000000503 Collagen Type II Human genes 0.000 claims description 14
108010041390 Collagen Type II Proteins 0.000 claims description 14
102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims description 14
101800002279 Transforming growth factor beta-1 Proteins 0.000 claims description 14
230000012010 growth Effects 0.000 claims description 14
102000043253 matrix Gla protein Human genes 0.000 claims description 14
108010057546 matrix Gla protein Proteins 0.000 claims description 14
102000002938 Thrombospondin Human genes 0.000 claims description 13
108060008245 Thrombospondin Proteins 0.000 claims description 13
210000002950 fibroblast Anatomy 0.000 claims description 13
238000013268 sustained release Methods 0.000 claims description 13
239000012730 sustained-release form Substances 0.000 claims description 13
108090000100 Hepatocyte Growth Factor Proteins 0.000 claims description 12
102000004877 Insulin Human genes 0.000 claims description 12
108090001061 Insulin Proteins 0.000 claims description 12
102000006747 Transforming Growth Factor alpha Human genes 0.000 claims description 12
101800004564 Transforming growth factor alpha Proteins 0.000 claims description 12
229940125396 insulin Drugs 0.000 claims description 12
102100022545 Bone morphogenetic protein 8B Human genes 0.000 claims description 11
108010090290 Growth Differentiation Factor 2 Proteins 0.000 claims description 11
102100040892 Growth/differentiation factor 2 Human genes 0.000 claims description 11
101000899368 Homo sapiens Bone morphogenetic protein 8B Proteins 0.000 claims description 11
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 11
230000006698 induction Effects 0.000 claims description 10
108010046018 leukocyte inhibitory factor Proteins 0.000 claims description 10
108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 9
102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 9
230000004663 cell proliferation Effects 0.000 claims description 9
229920001287 Chondroitin sulfate Polymers 0.000 claims description 8
102000004895 Lipoproteins Human genes 0.000 claims description 8
108090001030 Lipoproteins Proteins 0.000 claims description 8
230000002378 acidificating effect Effects 0.000 claims description 8
229940059329 chondroitin sulfate Drugs 0.000 claims description 8
238000004519 manufacturing process Methods 0.000 claims description 8
230000033115 angiogenesis Effects 0.000 claims description 7
229940099456 transforming growth factor beta 1 Drugs 0.000 claims description 7
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 7
NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 claims description 6
108010081589 Becaplermin Proteins 0.000 claims description 6
102000004954 Biglycan Human genes 0.000 claims description 6
108090001138 Biglycan Proteins 0.000 claims description 6
102000004237 Decorin Human genes 0.000 claims description 6
108090000738 Decorin Proteins 0.000 claims description 6
108090000367 Fibroblast growth factor 9 Proteins 0.000 claims description 6
102100037665 Fibroblast growth factor 9 Human genes 0.000 claims description 6
108010067306 Fibronectins Proteins 0.000 claims description 6
102000016359 Fibronectins Human genes 0.000 claims description 6
102000003886 Glycoproteins Human genes 0.000 claims description 6
108090000288 Glycoproteins Proteins 0.000 claims description 6
108010051696 Growth Hormone Proteins 0.000 claims description 6
102000003693 Hedgehog Proteins Human genes 0.000 claims description 6
108090000031 Hedgehog Proteins Proteins 0.000 claims description 6
102000048143 Insulin-Like Growth Factor II Human genes 0.000 claims description 6
108090001117 Insulin-Like Growth Factor II Proteins 0.000 claims description 6
102000004264 Osteopontin Human genes 0.000 claims description 6
108010081689 Osteopontin Proteins 0.000 claims description 6
AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 claims description 6
102000015395 alpha 1-Antitrypsin Human genes 0.000 claims description 6
108010050122 alpha 1-Antitrypsin Proteins 0.000 claims description 6
229940024142 alpha 1-antitrypsin Drugs 0.000 claims description 6
102000015736 beta 2-Microglobulin Human genes 0.000 claims description 6
108010081355 beta 2-Microglobulin Proteins 0.000 claims description 6
230000004709 cell invasion Effects 0.000 claims description 6
239000000122 growth hormone Substances 0.000 claims description 6
230000000921 morphogenic effect Effects 0.000 claims description 6
230000001817 pituitary effect Effects 0.000 claims description 6
239000005495 thyroid hormone Substances 0.000 claims description 6
229940036555 thyroid hormone Drugs 0.000 claims description 6
108010000685 platelet-derived growth factor AB Proteins 0.000 claims description 5
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims description 4
102000003971 Fibroblast Growth Factor 1 Human genes 0.000 claims description 2
206010072970 Meniscus injury Diseases 0.000 claims description 2
239000010409 thin film Substances 0.000 claims description 2
102100021866 Hepatocyte growth factor Human genes 0.000 claims 2
102100037114 Elongin-C Human genes 0.000 claims 1
102000018997 Growth Hormone Human genes 0.000 claims 1
101001011859 Homo sapiens Elongin-A Proteins 0.000 claims 1
101001011846 Homo sapiens Elongin-B Proteins 0.000 claims 1
101000881731 Homo sapiens Elongin-C Proteins 0.000 claims 1
101000836005 Homo sapiens S-phase kinase-associated protein 1 Proteins 0.000 claims 1
102000012005 alpha-2-HS-Glycoprotein Human genes 0.000 claims 1
108010075843 alpha-2-HS-Glycoprotein Proteins 0.000 claims 1
239000012528 membrane Substances 0.000 claims 1
210000001519 tissue Anatomy 0.000 abstract description 53
239000000463 material Substances 0.000 abstract description 15
230000008929 regeneration Effects 0.000 abstract description 5
238000011069 regeneration method Methods 0.000 abstract description 5
235000018102 proteins Nutrition 0.000 description 532
230000022159 cartilage development Effects 0.000 description 106
210000004027 cell Anatomy 0.000 description 101
150000007523 nucleic acids Chemical group 0.000 description 70
108020004707 nucleic acids Proteins 0.000 description 66
102000039446 nucleic acids Human genes 0.000 description 66
230000002708 enhancing effect Effects 0.000 description 54
238000001727 in vivo Methods 0.000 description 40
230000005499 meniscus Effects 0.000 description 39
230000011164 ossification Effects 0.000 description 25
241000700159 Rattus Species 0.000 description 23
230000001965 increasing effect Effects 0.000 description 20
230000002138 osteoinductive effect Effects 0.000 description 19
206010007710 Cartilage injury Diseases 0.000 description 17
239000000243 solution Substances 0.000 description 17
238000000338 in vitro Methods 0.000 description 16
239000002609 medium Substances 0.000 description 15
239000003981 vehicle Substances 0.000 description 15
102000005666 Apolipoprotein A-I Human genes 0.000 description 14
108010059886 Apolipoprotein A-I Proteins 0.000 description 14
241000283984 Rodentia Species 0.000 description 14
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
230000006870 function Effects 0.000 description 13
239000007943 implant Substances 0.000 description 13
238000010186 staining Methods 0.000 description 13
102000009618 Transforming Growth Factors Human genes 0.000 description 12
108010009583 Transforming Growth Factors Proteins 0.000 description 12
229960000074 biopharmaceutical Drugs 0.000 description 12
238000002474 experimental method Methods 0.000 description 12
150000001413 amino acids Chemical class 0.000 description 11
102000003745 Hepatocyte Growth Factor Human genes 0.000 description 10
241001465754 Metazoa Species 0.000 description 10
230000015572 biosynthetic process Effects 0.000 description 10
230000006378 damage Effects 0.000 description 10
230000000694 effects Effects 0.000 description 10
210000003127 knee Anatomy 0.000 description 10
239000002502 liposome Substances 0.000 description 10
210000002966 serum Anatomy 0.000 description 10
239000000126 substance Substances 0.000 description 10
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
102000012422 Collagen Type I Human genes 0.000 description 9
108010022452 Collagen Type I Proteins 0.000 description 9
102000016611 Proteoglycans Human genes 0.000 description 9
108010067787 Proteoglycans Proteins 0.000 description 9
230000004927 fusion Effects 0.000 description 9
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 9
238000002271 resection Methods 0.000 description 9
238000001356 surgical procedure Methods 0.000 description 9
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
244000309466 calf Species 0.000 description 8
239000000515 collagen sponge Substances 0.000 description 8
239000000499 gel Substances 0.000 description 8
241000283707 Capra Species 0.000 description 7
229920000954 Polyglycolide Polymers 0.000 description 7
238000010586 diagram Methods 0.000 description 7
230000006872 improvement Effects 0.000 description 7
239000000546 pharmaceutical excipient Substances 0.000 description 7
DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 6
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
241000700605 Viruses Species 0.000 description 6
238000004128 high performance liquid chromatography Methods 0.000 description 6
210000002901 mesenchymal stem cell Anatomy 0.000 description 6
238000000746 purification Methods 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
241000283973 Oryctolagus cuniculus Species 0.000 description 5
102100038803 Somatotropin Human genes 0.000 description 5
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
239000002253 acid Substances 0.000 description 5
238000005349 anion exchange Methods 0.000 description 5
-1 but not limited to Proteins 0.000 description 5
239000000512 collagen gel Substances 0.000 description 5
229950003499 fibrin Drugs 0.000 description 5
230000035876 healing Effects 0.000 description 5
238000002513 implantation Methods 0.000 description 5
238000011534 incubation Methods 0.000 description 5
238000005259 measurement Methods 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
239000002077 nanosphere Substances 0.000 description 5
239000002953 phosphate buffered saline Substances 0.000 description 5
229920000747 poly(lactic acid) Polymers 0.000 description 5
239000004633 polyglycolic acid Substances 0.000 description 5
238000011002 quantification Methods 0.000 description 5
239000000523 sample Substances 0.000 description 5
238000011282 treatment Methods 0.000 description 5
BHLYRWXGMIUIHG-HNNXBMFYSA-N (S)-reticuline Chemical compound C1=C(O)C(OC)=CC=C1C[C@H]1C2=CC(O)=C(OC)C=C2CCN1C BHLYRWXGMIUIHG-HNNXBMFYSA-N 0.000 description 4
102000004266 Collagen Type IV Human genes 0.000 description 4
108010042086 Collagen Type IV Proteins 0.000 description 4
108020004414 DNA Proteins 0.000 description 4
102000009123 Fibrin Human genes 0.000 description 4
108010073385 Fibrin Proteins 0.000 description 4
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
108010090254 Growth Differentiation Factor 5 Proteins 0.000 description 4
101710167839 Morphogenetic protein Proteins 0.000 description 4
101100165554 Mus musculus Bmp5 gene Proteins 0.000 description 4
241000906034 Orthops Species 0.000 description 4
230000003321 amplification Effects 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
230000019552 anatomical structure morphogenesis Effects 0.000 description 4
235000010323 ascorbic acid Nutrition 0.000 description 4
229960005070 ascorbic acid Drugs 0.000 description 4
239000011668 ascorbic acid Substances 0.000 description 4
230000008901 benefit Effects 0.000 description 4
239000000872 buffer Substances 0.000 description 4
238000005341 cation exchange Methods 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
230000004069 differentiation Effects 0.000 description 4
239000000284 extract Substances 0.000 description 4
210000000968 fibrocartilage Anatomy 0.000 description 4
210000003035 hyaline cartilage Anatomy 0.000 description 4
229920002674 hyaluronan Polymers 0.000 description 4
230000008595 infiltration Effects 0.000 description 4
238000001764 infiltration Methods 0.000 description 4
230000010354 integration Effects 0.000 description 4
229920005615 natural polymer Polymers 0.000 description 4
230000007935 neutral effect Effects 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
239000011148 porous material Substances 0.000 description 4
102000004196 processed proteins & peptides Human genes 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
239000004575 stone Substances 0.000 description 4
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 4
210000002303 tibia Anatomy 0.000 description 4
230000009261 transgenic effect Effects 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 3
101500027530 Bos taurus Transforming growth factor beta-1 Proteins 0.000 description 3
229920002683 Glycosaminoglycan Polymers 0.000 description 3
102100035379 Growth/differentiation factor 5 Human genes 0.000 description 3
101500025614 Homo sapiens Transforming growth factor beta-1 Proteins 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
241001447056 Uristes Species 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
229960000583 acetic acid Drugs 0.000 description 3
230000004071 biological effect Effects 0.000 description 3
210000004204 blood vessel Anatomy 0.000 description 3
230000003848 cartilage regeneration Effects 0.000 description 3
108010027904 cartilage-derived-morphogenetic protein-2 Proteins 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
238000004132 cross linking Methods 0.000 description 3
238000012258 culturing Methods 0.000 description 3
230000002950 deficient Effects 0.000 description 3
239000008367 deionised water Substances 0.000 description 3
229910021641 deionized water Inorganic materials 0.000 description 3
239000006185 dispersion Substances 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
239000000835 fiber Substances 0.000 description 3
238000010562 histological examination Methods 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
208000014674 injury Diseases 0.000 description 3
PQLXHQMOHUQAKB-UHFFFAOYSA-N miltefosine Chemical compound CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C PQLXHQMOHUQAKB-UHFFFAOYSA-N 0.000 description 3
210000003098 myoblast Anatomy 0.000 description 3
239000002773 nucleotide Substances 0.000 description 3
125000003729 nucleotide group Chemical group 0.000 description 3
230000005868 ontogenesis Effects 0.000 description 3
201000008482 osteoarthritis Diseases 0.000 description 3
238000003752 polymerase chain reaction Methods 0.000 description 3
239000002243 precursor Substances 0.000 description 3
230000006798 recombination Effects 0.000 description 3
238000005215 recombination Methods 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
239000007858 starting material Substances 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
230000009466 transformation Effects 0.000 description 3
230000001131 transforming effect Effects 0.000 description 3
210000000689 upper leg Anatomy 0.000 description 3
230000003966 vascular damage Effects 0.000 description 3
238000001262 western blot Methods 0.000 description 3
RUPUUZZJJXCDHS-UHFFFAOYSA-N (+)-orientaline Natural products C1=C(O)C(OC)=CC(CC2C3=CC(O)=C(OC)C=C3CCN2C)=C1 RUPUUZZJJXCDHS-UHFFFAOYSA-N 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
206010002091 Anaesthesia Diseases 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
102000001187 Collagen Type III Human genes 0.000 description 2
108010069502 Collagen Type III Proteins 0.000 description 2
229920000045 Dermatan sulfate Polymers 0.000 description 2
102000016942 Elastin Human genes 0.000 description 2
108010014258 Elastin Proteins 0.000 description 2
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
102100031706 Fibroblast growth factor 1 Human genes 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
229920002971 Heparan sulfate Polymers 0.000 description 2
WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
229920000288 Keratan sulfate Polymers 0.000 description 2
102000003505 Myosin Human genes 0.000 description 2
108060008487 Myosin Proteins 0.000 description 2
108091028043 Nucleic acid sequence Proteins 0.000 description 2
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
229930040373 Paraformaldehyde Natural products 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
101100218949 Rattus norvegicus Bmp3 gene Proteins 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
102000002278 Ribosomal Proteins Human genes 0.000 description 2
108010000605 Ribosomal Proteins Proteins 0.000 description 2
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 2
101800000304 Transforming growth factor beta-2 Proteins 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
230000037005 anaesthesia Effects 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
230000033558 biomineral tissue development Effects 0.000 description 2
239000002775 capsule Substances 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000000969 carrier Substances 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
230000003399 chemotactic effect Effects 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
230000037319 collagen production Effects 0.000 description 2
210000004439 collateral ligament Anatomy 0.000 description 2
210000002808 connective tissue Anatomy 0.000 description 2
239000000470 constituent Substances 0.000 description 2
AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 2
229940051593 dermatan sulfate Drugs 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
239000000975 dye Substances 0.000 description 2
229920002549 elastin Polymers 0.000 description 2
210000002308 embryonic cell Anatomy 0.000 description 2
230000035194 endochondral ossification Effects 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
210000002744 extracellular matrix Anatomy 0.000 description 2
238000000605 extraction Methods 0.000 description 2
229940126864 fibroblast growth factor Drugs 0.000 description 2
239000012634 fragment Substances 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
102000037865 fusion proteins Human genes 0.000 description 2
108020001507 fusion proteins Proteins 0.000 description 2
150000002334 glycols Chemical class 0.000 description 2
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
229940099552 hyaluronan Drugs 0.000 description 2
KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 2
229960003160 hyaluronic acid Drugs 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
239000000543 intermediate Substances 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
210000002414 leg Anatomy 0.000 description 2
210000003041 ligament Anatomy 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
230000035800 maturation Effects 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
244000005700 microbiome Species 0.000 description 2
238000000386 microscopy Methods 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
230000021688 musculoskeletal movement Effects 0.000 description 2
238000002703 mutagenesis Methods 0.000 description 2
231100000350 mutagenesis Toxicity 0.000 description 2
230000017074 necrotic cell death Effects 0.000 description 2
QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
239000003921 oil Substances 0.000 description 2
230000000399 orthopedic effect Effects 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
206010033675 panniculitis Diseases 0.000 description 2
229920002866 paraformaldehyde Polymers 0.000 description 2
239000002245 particle Substances 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
239000004626 polylactic acid Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
230000008569 process Effects 0.000 description 2
BNUZUOWRDKPBQR-UHFFFAOYSA-N reticuline Natural products CN1CCC2=CC(OC)=CC=C2C1CC1=CC=C(OC)C(O)=C1 BNUZUOWRDKPBQR-UHFFFAOYSA-N 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000012216 screening Methods 0.000 description 2
229910000077 silane Inorganic materials 0.000 description 2
230000022379 skeletal muscle tissue development Effects 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
238000007390 skin biopsy Methods 0.000 description 2
210000004927 skin cell Anatomy 0.000 description 2
235000002639 sodium chloride Nutrition 0.000 description 2
239000007787 solid Substances 0.000 description 2
210000000130 stem cell Anatomy 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
210000004304 subcutaneous tissue Anatomy 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
229920001059 synthetic polymer Polymers 0.000 description 2
238000012360 testing method Methods 0.000 description 2
210000004353 tibial menisci Anatomy 0.000 description 2
230000008467 tissue growth Effects 0.000 description 2
210000003556 vascular endothelial cell Anatomy 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
239000008096 xylene Substances 0.000 description 2
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
DLZKEQQWXODGGZ-KCJUWKMLSA-N 2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DLZKEQQWXODGGZ-KCJUWKMLSA-N 0.000 description 1
CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
101000839391 Alligator mississippiensis Sperm protamine P1-type Proteins 0.000 description 1
241000710929 Alphavirus Species 0.000 description 1
101000961187 Anacardium occidentale 11S globulin seed storage protein Ana o 2.0101 Proteins 0.000 description 1
102100022987 Angiogenin Human genes 0.000 description 1
101100316860 Autographa californica nuclear polyhedrosis virus DA18 gene Proteins 0.000 description 1
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 description 1
108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 description 1
239000011547 Bouin solution Substances 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
102100027207 CD27 antigen Human genes 0.000 description 1
108010061299 CXCR4 Receptors Proteins 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
102100024436 Caldesmon Human genes 0.000 description 1
108050007758 Caldesmon Proteins 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
102100033668 Cartilage matrix protein Human genes 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
102000037716 Chondroitin-sulfate-ABC endolyases Human genes 0.000 description 1
108090000819 Chondroitin-sulfate-ABC endolyases Proteins 0.000 description 1
206010061762 Chondropathy Diseases 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
101710141836 DNA-binding protein HU homolog Proteins 0.000 description 1
229920004943 Delrin® Polymers 0.000 description 1
102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
102100033183 Epithelial membrane protein 1 Human genes 0.000 description 1
239000004593 Epoxy Substances 0.000 description 1
241000289669 Erinaceus europaeus Species 0.000 description 1
108010071289 Factor XIII Proteins 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 1
IGBBBLSQXFDCHI-MIDKXNQYSA-N Glucoselysine Chemical compound N[C@@H](CCCCN[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O)C(O)=O IGBBBLSQXFDCHI-MIDKXNQYSA-N 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
102000012966 Growth Differentiation Factor 5 Human genes 0.000 description 1
102100035368 Growth/differentiation factor 6 Human genes 0.000 description 1
101710204281 Growth/differentiation factor 6 Proteins 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 1
101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
101001018382 Homo sapiens Cartilage matrix protein Proteins 0.000 description 1
101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 description 1
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
102100025304 Integrin beta-1 Human genes 0.000 description 1
PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
ODYCAZSSUVCHNU-XLAORIBOSA-N Laurencin Natural products CC[C@H]1C[C@H](CC=CC[C@@H]1Br)[C@@H](CC=CC#C)OC(=O)C ODYCAZSSUVCHNU-XLAORIBOSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
102000055008 Matrilin Proteins Human genes 0.000 description 1
108010072582 Matrilin Proteins Proteins 0.000 description 1
101710174628 Modulating protein YmoA Proteins 0.000 description 1
101100004031 Mus musculus Aven gene Proteins 0.000 description 1
101100165560 Mus musculus Bmp7 gene Proteins 0.000 description 1
101100207506 Mus musculus Trim29 gene Proteins 0.000 description 1
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
102100037596 Platelet-derived growth factor subunit A Human genes 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
101710112672 Probable tape measure protein Proteins 0.000 description 1
239000004792 Prolene Substances 0.000 description 1
241000219061 Rheum Species 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
102000043168 TGF-beta family Human genes 0.000 description 1
108091085018 TGF-beta family Proteins 0.000 description 1
108091005735 TGF-beta receptors Proteins 0.000 description 1
101710204224 Tape measure protein Proteins 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
102000056172 Transforming growth factor beta-3 Human genes 0.000 description 1
108090000097 Transforming growth factor beta-3 Proteins 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
208000024248 Vascular System injury Diseases 0.000 description 1
208000012339 Vascular injury Diseases 0.000 description 1
206010053649 Vascular rupture Diseases 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000002730 additional effect Effects 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
108010001122 alpha(2)-microglobulin Proteins 0.000 description 1
AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
230000009435 amidation Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
239000002870 angiogenesis inducing agent Substances 0.000 description 1
230000002491 angiogenic effect Effects 0.000 description 1
108010072788 angiogenin Proteins 0.000 description 1
238000005571 anion exchange chromatography Methods 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
230000003302 anti-idiotype Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000008365 aqueous carrier Substances 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
229920000249 biocompatible polymer Polymers 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000001045 blue dye Substances 0.000 description 1
230000008468 bone growth Effects 0.000 description 1
230000002308 calcification Effects 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
235000011148 calcium chloride Nutrition 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
150000001720 carbohydrates Chemical group 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
229910002091 carbon monoxide Inorganic materials 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000035605 chemotaxis Effects 0.000 description 1
238000010367 cloning Methods 0.000 description 1
238000012411 cloning technique Methods 0.000 description 1
238000004040 coloring Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
230000000536 complexating effect Effects 0.000 description 1
239000002131 composite material Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
230000001054 cortical effect Effects 0.000 description 1
238000002788 crimping Methods 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
125000005442 diisocyanate group Chemical group 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000002845 discoloration Methods 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000011833 dog model Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
108060002430 dynein heavy chain Proteins 0.000 description 1
102000013035 dynein heavy chain Human genes 0.000 description 1
230000004821 effect on bone Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
229940012444 factor xiii Drugs 0.000 description 1
210000003195 fascia Anatomy 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
210000002082 fibula Anatomy 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000010408 film Substances 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000012215 gene cloning Methods 0.000 description 1
238000001476 gene delivery Methods 0.000 description 1
AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
229960000789 guanidine hydrochloride Drugs 0.000 description 1
230000036541 health Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
102000045896 human BMP2 Human genes 0.000 description 1
210000004276 hyalin Anatomy 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000001969 hypertrophic effect Effects 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
238000003365 immunocytochemistry Methods 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
239000003983 inhalation anesthetic agent Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000007689 inspection Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000009545 invasion Effects 0.000 description 1
229960002725 isoflurane Drugs 0.000 description 1
210000000629 knee joint Anatomy 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000011670 long-evans rat Methods 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
238000005461 lubrication Methods 0.000 description 1
210000004705 lumbosacral region Anatomy 0.000 description 1
239000013028 medium composition Substances 0.000 description 1
210000004779 membrane envelope Anatomy 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical group O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
IPSIPYMEZZPCPY-UHFFFAOYSA-N new fuchsin Chemical compound [Cl-].C1=CC(=[NH2+])C(C)=CC1=C(C=1C=C(C)C(N)=CC=1)C1=CC=C(N)C(C)=C1 IPSIPYMEZZPCPY-UHFFFAOYSA-N 0.000 description 1
238000011587 new zealand white rabbit Methods 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
238000005457 optimization Methods 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
210000000963 osteoblast Anatomy 0.000 description 1
230000004819 osteoinduction Effects 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
230000036407 pain Effects 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
229960001412 pentobarbital Drugs 0.000 description 1
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
RDBMUARQWLPMNW-UHFFFAOYSA-N phosphanylmethanol Chemical compound OCP RDBMUARQWLPMNW-UHFFFAOYSA-N 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
108010017843 platelet-derived growth factor A Proteins 0.000 description 1
230000010287 polarization Effects 0.000 description 1
239000002861 polymer material Substances 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
235000004252 protein component Nutrition 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002787 reinforcement Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
239000002002 slurry Substances 0.000 description 1
AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001540 sodium lactate Substances 0.000 description 1
235000011088 sodium lactate Nutrition 0.000 description 1
229940005581 sodium lactate Drugs 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
238000007447 staining method Methods 0.000 description 1
239000012192 staining solution Substances 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
210000001258 synovial membrane Anatomy 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
230000009772 tissue formation Effects 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
230000007556 vascular defect Effects 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000011800 void material Substances 0.000 description 1
238000005303 weighing Methods 0.000 description 1